Literature DB >> 3058818

Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes.

G Dougan1, S Chatfield, D Pickard, J Bester, D O'Callaghan, D Maskell.   

Abstract

Derivatives of the mouse-virulent Salmonella typhimurium strain SL1344 were constructed harboring stable mutations in aroC alone or in aroC and aroA together. Fifty percent lethal doses after intravenous inoculation of the mutants into BALB/c mice were determined, and the mutants were as highly attenuated as were SL1344 aroA derivatives. All aro-dependent derivatives persisted in vivo at similar levels and for similar intervals in the livers and spleens of BALB/c mice infected intravenously. Mice vaccinated orally with 10(10) live organisms of the different derivatives survived and were well protected against oral challenge with virulent S. typhimurium. A Salmonella typhi Ty2 derivative, designated WBL2000, was constructed that harbors well-defined, stable mutations in both aroA and aroC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058818     DOI: 10.1093/infdis/158.6.1329

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Complete nucleotide sequence of the aroA gene from Salmonella typhi encoding 5-enolpyruvylshikimate 3-phosphate synthase.

Authors:  S Chatfield; G Dougan; I Charles
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

4.  Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.

Authors:  D M Hone; C O Tacket; A M Harris; B Kay; G Losonsky; M M Levine
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

Authors:  J X Bao; J D Clements
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Metabolic Alterations Contribute to Enhanced Inflammatory Cytokine Production in Irgm1-deficient Macrophages.

Authors:  Elyse A Schmidt; Brian E Fee; Stanley C Henry; Amanda G Nichols; Mari L Shinohara; Jeffrey C Rathmell; Nancie J MacIver; Jörn Coers; Olga R Ilkayeva; Timothy R Koves; Gregory A Taylor
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

7.  Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains.

Authors:  D O'Callaghan; D Maskell; J Tite; G Dougan
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

Review 8.  Oral vaccination.

Authors:  G Dougan; D Maskell; D O'Callaghan; S Chatfield; I Charles; C Hormaeche
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

9.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice.

Authors:  Roy R Chaudhuri; Sarah E Peters; Stephen J Pleasance; Helen Northen; Chrissie Willers; Gavin K Paterson; Danielle B Cone; Andrew G Allen; Paul J Owen; Gil Shalom; Dov J Stekel; Ian G Charles; Duncan J Maskell
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.